Correlation Between Alphabet and Franklin Genomic

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alphabet and Franklin Genomic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Franklin Genomic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Franklin Genomic Advancements, you can compare the effects of market volatilities on Alphabet and Franklin Genomic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Franklin Genomic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Franklin Genomic.

Diversification Opportunities for Alphabet and Franklin Genomic

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Alphabet and Franklin is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Franklin Genomic Advancements in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Genomic Adv and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Franklin Genomic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Genomic Adv has no effect on the direction of Alphabet i.e., Alphabet and Franklin Genomic go up and down completely randomly.

Pair Corralation between Alphabet and Franklin Genomic

Given the investment horizon of 90 days Alphabet Inc Class C is expected to generate 1.28 times more return on investment than Franklin Genomic. However, Alphabet is 1.28 times more volatile than Franklin Genomic Advancements. It trades about 0.0 of its potential returns per unit of risk. Franklin Genomic Advancements is currently generating about -0.08 per unit of risk. If you would invest  16,699  in Alphabet Inc Class C on August 26, 2024 and sell it today you would lose (42.00) from holding Alphabet Inc Class C or give up 0.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Alphabet Inc Class C  vs.  Franklin Genomic Advancements

 Performance 
       Timeline  
Alphabet Class C 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alphabet Inc Class C has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Alphabet is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Franklin Genomic Adv 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Franklin Genomic Advancements has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Etf's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.

Alphabet and Franklin Genomic Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alphabet and Franklin Genomic

The main advantage of trading using opposite Alphabet and Franklin Genomic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Franklin Genomic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Genomic will offset losses from the drop in Franklin Genomic's long position.
The idea behind Alphabet Inc Class C and Franklin Genomic Advancements pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments